Proposed Section Structure
This article is organized into: Highlights; Clinical Background and Unmet Need; Study Design and Methods; Key Results; Phenotype-Specific Interpretation; Clinical and Public Health Implications; Strengths and Limitations; Conclusion; Funding and Registration; References.
Highlights
In a large registry-based analysis of 26,874 patients with acute decompensated heart failure (ADHF) in Tokyo, very low ambient temperature was associated with a substantially higher short-term risk of hospitalization for ADHF.
The temperature effect was immediate, with the excess risk concentrated on the same day as exposure rather than after several delayed lag days.
Older adults, particularly those aged 70 years or older, appeared more vulnerable to cold-related decompensation.
Most importantly, temperature sensitivity varied by hemodynamic presentation: ADHF accompanied by hypertension increased in cold conditions, whereas ADHF with low blood pressure showed the opposite pattern, with risk rising at high temperatures.
Clinical Background and Unmet Need
Acute decompensated heart failure remains a leading cause of emergency hospitalization, morbidity, and healthcare utilization worldwide. Although clinicians have long recognized that heart failure admissions cluster seasonally, especially during winter, seasonal patterns alone do not establish whether temperature itself is a proximate trigger. Cold weather can coincide with respiratory infections, changes in physical activity, holiday-related dietary shifts, and other environmental exposures. Disentangling the short-term contribution of ambient temperature from broader seasonality is therefore clinically important.
This question is increasingly relevant in the context of climate variability and population aging. Patients with heart failure often have impaired cardiovascular reserve, autonomic dysfunction, renal vulnerability, and reduced ability to compensate for abrupt environmental stress. Older adults may be especially susceptible because of frailty, impaired thermoregulation, and a high burden of comorbidity. Yet most prior work has focused on all-cause cardiovascular outcomes or total heart failure admissions without addressing whether distinct clinical phenotypes of ADHF respond differently to temperature.
That gap matters. ADHF is a syndrome, not a single biological entity. Some patients present with hypertensive pulmonary congestion and marked afterload excess, whereas others present with hypotension, low output, or advanced circulatory compromise. If weather-related triggers differ across these phenotypes, preventive advice and surveillance strategies should also differ. The present study addresses that issue directly.
Study Design and Methods
Jimba and colleagues analyzed 26,874 patients with ADHF registered in the Tokyo Coronary Care Unit Network Database from January 2014 through December 2019. The onset date of ADHF leading to hospitalization was identified, and participating cardiologists recorded clinical features including age, left ventricular function, cause of ADHF, and hemodynamic profile.
Ambient climate data were obtained from an observatory located near the admitting hospital. To assess short-term associations between temperature exposure and ADHF onset, the investigators used a time-stratified case-crossover design combined with distributed lag nonlinear models. This methodological pairing is well suited to transient environmental exposures. In a case-crossover framework, each patient serves as his or her own control, which minimizes confounding by stable individual characteristics such as sex, baseline comorbidity, socioeconomic profile, or long-standing medication use. The time-stratified approach also helps control for seasonality, day-of-week effects, and longer temporal trends.
The distributed lag nonlinear model allowed the authors to estimate both nonlinear exposure-response relationships and the timing of effects across lag days 0 to 5. The main comparisons used extreme temperatures relative to the temperature associated with the lowest observed risk. In this dataset, the first percentile corresponded to -4.5 degrees C and the 99th percentile to 29.0 degrees C, the latter also representing the minimum-risk reference temperature in the primary analysis.
Key Results
Overall association between temperature and ADHF
Exposure to extremely low temperature was associated with a marked increase in ADHF risk. Compared with 29.0 degrees C, exposure to -4.5 degrees C was associated with an odds ratio of 1.80, with a 95% confidence interval of 1.40 to 2.31. This indicates an approximately 80% relative increase in the odds of hospitalization for ADHF at the cold extreme.
The temporal pattern is clinically informative. The excess risk from low temperature emerged immediately on the day of exposure, at lag 0, rather than accumulating gradually over subsequent days. This finding supports the idea that cold exposure may act as an acute trigger of decompensation in susceptible individuals, potentially through rapid hemodynamic and neurohormonal mechanisms.
Age-specific vulnerability
The cold-related increase in risk was greater among patients aged 70 years or older. Although the abstract does not provide a full matrix of subgroup-specific estimates, the direction of effect suggests that advanced age modifies susceptibility. This is biologically plausible. Older adults may have less efficient vasomotor adaptation, more advanced diastolic dysfunction, greater arterial stiffness, and reduced behavioral capacity to avoid adverse exposure.
Consistency across major clinical subgroups
Outside the age interaction, the study reports that the low-temperature signal was otherwise broadly consistent across subgroups. That consistency is useful because it suggests that cold is not merely acting through one narrow subtype of heart failure, such as reduced ejection fraction alone or a single causal mechanism. Rather, low ambient temperature may represent a common precipitant across a broad spectrum of ADHF presentations.
Hemodynamic phenotype-specific differences
The most novel finding was that the temperature-risk relationship differed according to hemodynamic presentation. For ADHF accompanied by hypertension, risk increased as ambient temperature fell. This aligns with a clinically recognizable winter phenotype of acute pulmonary edema or congestion associated with elevated vascular tone and increased afterload.
By contrast, ADHF with low blood pressure showed the opposite pattern. In this subgroup, risk increased at high temperatures, with an odds ratio of 6.25 at the 99th percentile and a 95% confidence interval of 1.07 to 36.6. Although the confidence interval is wide, likely reflecting smaller event numbers in this subgroup, the directional signal is striking and hypothesis-generating. It suggests that heat exposure may be particularly destabilizing for patients predisposed to low-output or vasodilatory presentations.
Phenotype-Specific Interpretation
Why cold may precipitate hypertensive ADHF
Cold exposure triggers peripheral vasoconstriction, increases sympathetic nervous system activity, and can raise systemic vascular resistance and arterial pressure. In patients with impaired cardiac reserve, even a modest increase in afterload may rapidly elevate left ventricular filling pressures and provoke pulmonary congestion. Cold may also increase blood viscosity, platelet activation, and myocardial oxygen demand, while reducing physical comfort and mobility. Together, these effects can transform compensated chronic heart failure into an acute hypertensive decompensation.
The study’s same-day lag structure fits this physiology. Vasoconstriction and blood pressure elevation can occur within minutes to hours of exposure, making immediate decompensation credible, particularly in elderly patients with stiff vasculature, diastolic dysfunction, or incomplete neurohormonal blockade.
Why heat may matter in low-blood-pressure presentations
The association between high temperature and hypotensive ADHF is less intuitive but equally important. Heat exposure promotes cutaneous vasodilation, insensible fluid loss, and dehydration. In patients with advanced heart failure, these changes may reduce effective circulating volume or aggravate renal dysfunction, particularly in the setting of diuretic therapy, poor oral intake, or autonomic impairment. Heat may therefore precipitate a low-pressure phenotype characterized by reduced perfusion, worsening fatigue, or cardiorenal instability rather than overt hypertensive congestion.
Another possibility is that high temperature disproportionately affects frailer or more advanced patients who are less able to maintain hydration or adjust medications appropriately. Because the estimate is imprecise, this subgroup observation should be replicated, but it has immediate face validity for clinicians caring for patients with advanced heart failure during heat waves.
Clinical and Public Health Implications
This study supports incorporating short-term temperature exposure into practical risk assessment for heart failure. The key message is not simply that “winter is worse.” Rather, clinicians should think in terms of acute environmental triggers acting on vulnerable phenotypes.
For older patients with a history of congestion, elevated blood pressure during exacerbations, or recurrent winter admissions, cold-weather prevention may deserve more attention. This can include ensuring indoor heating, reinforcing adherence to vasodilator and diuretic regimens when appropriate, maintaining influenza and respiratory infection prevention, and advising patients to avoid abrupt cold exposure. Remote monitoring systems that track weight, symptoms, and blood pressure may be especially useful during cold spells.
For patients with advanced heart failure, low blood pressure, marginal renal function, or high diuretic sensitivity, heat-related guidance may be equally important. Medication plans may need seasonal flexibility, particularly regarding diuretic intensity and hydration counseling. Patients and caregivers should receive clear advice about fluid balance, warning symptoms, and when to seek evaluation during hot weather.
At a systems level, the findings also matter for emergency preparedness and hospital operations. Weather forecasting is increasingly precise. Integrating temperature alerts with heart failure outreach programs could allow targeted contact with high-risk patients before anticipated cold snaps or heat extremes. Such an approach would align cardiology practice with climate-aware preventive medicine.
Strengths and Limitations
Strengths
The study has several notable strengths. First, the sample size is large for an environmentally focused heart failure analysis, with 26,874 ADHF events. Second, the registry captured clinically adjudicated presentation details rather than relying solely on administrative coding. Third, the time-stratified case-crossover design is a strong approach for studying transient triggers because it inherently controls for fixed individual-level confounders. Fourth, the distributed lag nonlinear framework appropriately models nonlinear and immediate versus delayed effects.
Most importantly, the analysis moves beyond total admissions and examines phenotype-specific vulnerability. That step gives the findings practical clinical meaning rather than leaving them at the level of epidemiologic association alone.
Limitations
Several caveats should temper interpretation. Ambient temperature measured at observatories is an imperfect proxy for individual exposure. Indoor temperature, housing quality, time spent outdoors, and use of heating or air conditioning were not captured. Residual confounding from co-occurring factors such as viral epidemics, air pollution, humidity, or behavioral changes cannot be completely excluded.
The study population comes from the Tokyo Coronary Care Unit Network, so generalizability to rural settings, different climates, or health systems may be limited. The minimum-risk temperature of 29.0 degrees C is specific to this dataset and should not be generalized as a universal optimum. The heat-related finding in low-blood-pressure ADHF is intriguing but imprecise, as shown by the wide confidence interval, and requires confirmation in external cohorts.
Finally, observational environmental studies can identify associations and plausible triggers but cannot prove causality at the individual level. Nonetheless, when biologic plausibility, temporal proximity, and internal consistency align as they do here, the findings are highly relevant to practice.
How This Fits With Current Knowledge
Current heart failure guidelines from major societies emphasize recognition of precipitating factors for decompensation, but environmental temperature rarely occupies a prominent place in routine counseling. This study suggests that omission may be too narrow, particularly in aging urban populations.
The findings are also consistent with broader cardiovascular literature showing increased adverse events during cold exposure, including higher rates of blood pressure elevation, myocardial infarction, and stroke in vulnerable populations. What distinguishes this report is the refinement of risk by ADHF phenotype. That shift from aggregate burden to clinical presentation is likely to become more important as medicine moves toward more personalized prevention.
Conclusion
This large time-stratified case-crossover study adds strong evidence that low ambient temperature is an immediate short-term trigger for acute heart failure decompensation, with especially pronounced vulnerability in older adults. The most clinically important insight is that temperature effects are not uniform across all ADHF presentations. Cold preferentially tracks with hypertensive decompensation, while heat may increase risk in hypotensive presentations.
For clinicians, the practical takeaway is straightforward: weather exposure should be considered part of heart failure risk stratification and patient counseling. For health systems and public health planners, targeted prevention during temperature extremes may reduce avoidable admissions. Future work should test whether phenotype-tailored climate advisories, remote monitoring, and seasonal medication management can translate these epidemiologic observations into fewer decompensations.
Funding and Registration
Registration: UMIN Clinical Trials Registry, UMIN000013128. URL: https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015310.
The abstract provided does not specify funding details. No additional funding information is added here to avoid unsupported attribution.
References
1. Jimba T, Kohsaka S, Shiraishi Y, Takei M, Harada K, Otsuka T, Shindo A, Kohno T, Nakano H, Matsuda J, Kitano D, Tsukamoto S, Koba S, Yamamoto T, Takeda N, Takayama M. Short-Term Effects of Ambient Temperature on Acute Heart Failure Decompensation: Phenotype-Specific Risk in a Time-Stratified Case-Crossover Study. Circulation: Heart Failure. 2026-05-28:e013934. PMID: 42206403.
2. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022;145:e895-e1032.
3. McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2023;44:3627-3639.
4. Stewart S, Keates AK, Redfern A, McMurray JJV. Seasonal variations in cardiovascular disease. Nature Reviews Cardiology. 2017;14:654-664.
